Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Assets Average (2016 - 2025)

Neuroone Medical Technologies' Assets Average history spans 11 years, with the latest figure at $9.7 million for Q4 2025.

  • For Q4 2025, Assets Average rose 63.2% year-over-year to $9.7 million; the TTM value through Dec 2025 reached $9.7 million, up 63.2%, while the annual FY2025 figure was $8.1 million, 19.96% up from the prior year.
  • Assets Average reached $9.7 million in Q4 2025 per NMTC's latest filing, down from $10.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $15.6 million in Q1 2022 to a low of $5.1 million in Q3 2024.
  • Average Assets Average over 5 years is $8.9 million, with a median of $8.7 million recorded in 2021.
  • Peak YoY movement for Assets Average: skyrocketed 207.08% in 2021, then plummeted 49.48% in 2023.
  • A 5-year view of Assets Average shows it stood at $12.6 million in 2021, then decreased by 10.51% to $11.2 million in 2022, then tumbled by 38.09% to $7.0 million in 2023, then fell by 14.77% to $5.9 million in 2024, then surged by 63.2% to $9.7 million in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Assets Average are $9.7 million (Q4 2025), $10.8 million (Q3 2025), and $7.6 million (Q2 2025).